Page last updated: 2024-11-09

2-thio-6-azathymine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID1263666
CHEMBL ID3272983
SCHEMBL ID130106
SCHEMBL ID9524752
MeSH IDM0047601

Synonyms (70)

Synonym
6-methyl-3-sulfanyl-1,2,4-triazin-5-ol
STK721922
nsc-1609
6-methyl-3-thio-as-triazine-3,4h)-dione
nsc1609
6-azathiothymine
6-aza-2-thiothymine ,
nsc-38618
nsc38618
NCIOPEN2_001908
SDCCGMLS-0065562.P001
615-76-9
nsc102906
nsc-102906
6-aza-2-thiothymine, 99%
EC-000.1632
3-mercapto-6-methyl-1,2,4-triazin-5(2h)-one
1,2,4-triazin-5(2h)-one, 3,4-dihydro-6-methyl-3-thioxo-
as-triazine-3,5(2h,4h)-dione, 6-methyl-3-thio-
nsc 1609
as-triazin-5-ol, 3-mercapto-6-methyl-
2-thio-6-azathymine
nsc 38618
nsc 102906
3-mercapto-6-methyl-as-triazin-5-ol
6-methyl-3-thio-as-triazine-3,5(2h,4h)-dione
3,4-dihydro-6-methyl-3-thioxo-1,2,4-triazin-5(2h)-one
einecs 210-445-4
AKOS000270509
3-mercapto-6-methyl-1,2,4-triazin-5(4h)-one
F0896-0373
6-methyl-3-thioxo-3,4-dihydro-2h-[1,2,4]triazin-5-one
F1285-1861
inchi=1/c4h5n3os/c1-2-3(8)5-4(9)7-6-2/h1h3,(h2,5,7,8,9)
nkopqosbrolofp-uhfffaoysa-
AKOS000122766
AKOS002860534
AKOS002286303
6-methyl-3-thioxo-2h-1,2,4-triazin-5-one
A833313
6-methyl-3-sulfanyl-1,2,4-triazin-5(4h)-one
STK789032
6-methyl-3-sulfanylidene-2h-1,2,4-triazin-5-one
6-methyl-3-thioxo-2h-[1,2,4]triazin-5-one
6-methyl-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2h)-one
unii-rhh0rio9kf
rhh0rio9kf ,
FT-0620950
CHEMBL3272983
STL477637
SCHEMBL130106
SCHEMBL9524752
6-methyl-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2h)-one #
6-methyl-3-thioxo-5-oxo-2,3,4,5-tetrahydro-1,2,4-triazine
DTXSID30210473
CCG-231082
mfcd00006458
Z56887779
6-methyl-3-sulfanylidene-2,3,4,5-tetrahydro-1,2,4-triazin-5-one
AS-69474
3-mercapto-5-hydroxy-6-methyl-1,2,4-triazine
5-methyl-2-thio-6-azauracil
2-thio-6-azathymine;6-azathiothymine;6-methyl-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2h)-one
BCP31508
SB73472
D94647
CS-0071621
6-methyl-3-sulfanyl-4,5-dihydro-1,2,4-triazin-5-one
EN300-25132
PD000819
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1148822Toxicity in trophozoite Plasmodium berghei infected in sc dosed mouse administered as single dose 72 hrs after parasite infection1976Journal of medicinal chemistry, Jun, Volume: 19, Issue:6
Antimalarials. 3. 1,2,4-Triazines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.25)18.7374
1990's3 (18.75)18.2507
2000's6 (37.50)29.6817
2010's5 (31.25)24.3611
2020's1 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.13 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]